跳到主要內容

臺灣博碩士論文加值系統

(3.236.84.188) 您好!臺灣時間:2021/07/30 03:06
字體大小: 字級放大   字級縮小   預設字形  
回查詢結果 :::

詳目顯示

: 
twitterline
研究生:林晞璿
研究生(外文):Lin, Shi-Shiuan
論文名稱:探討Psoralidin抑制脂多醣體誘導RAW264.7巨噬細胞產生一氧化氮之作用機制
論文名稱(外文):The Inhibitory Mechanisms of Psoralidin on Lipopolysaccharide (LPS)-induced Nitric Oxide Production in RAW264.7 Macrophages
指導教授:廖志飛廖志飛引用關係邱文慧邱文慧引用關係
指導教授(外文):Liao, Jyh-FeiChiou, Wen-Fei
學位類別:碩士
校院名稱:國立陽明大學
系所名稱:藥理學研究所
學門:醫藥衛生學門
學類:藥學學類
論文種類:學術論文
論文出版年:2009
畢業學年度:97
語文別:中文
論文頁數:77
中文關鍵詞:脂多醣體巨噬細胞一氧化氮
外文關鍵詞:LipopolysaccharideMacrophagesNitric Oxidepsoralidin
相關次數:
  • 被引用被引用:0
  • 點閱點閱:422
  • 評分評分:
  • 下載下載:37
  • 收藏至我的研究室書目清單書目收藏:0
Psoralidin是由中藥補骨脂(Psoralea corylifolia L.)所萃取而來的天然物。psoralidin曾被報導過,於小鼠腹腔分離出的巨噬細胞能抑制LPS 誘導之NO生成,但抑制NO的作用機轉還未釐清,因此,本論文利用LPS刺激RAW264.7巨噬細胞株活化TLR4的訊息傳導,結果顯示,psoralidin於濃度10、 20 和30 uM能濃度相關的抑制LPS誘導之NO生成,並干擾NF-kB/IkB/IKK和PI3K/Akt路徑活化,而不影響MAPK路徑,psoralidin亦能抑制LPS誘導之TAK1磷酸化和IRAK1活化。Syk已知參與TLR4的上游訊息傳導之調控,但詳細機轉不明,本論文利用syk 抑制劑(piceatannol)處理細胞可知,piceatannol能抑制LPS誘導之NO生成、NF-kB和PI3K/Akt路徑及IRAK1活化,但不影響IKK/IkB路徑。這些結果顯示psoralidin和Syk兩者抑制NO生合成的機制有部分相同。然而,由細胞處理IRAK1的siRNA後發現與已知機轉不同的是,抑制IRAK1活化並不影響LPS活化的IKK/IkB 路徑。因此,psoralidin抗發炎的藥理機轉,也許是分別抑制了LPS誘導之IRAK1活化、PI3K/Akt路徑和IKK/IkB路徑後,進而影響NF-kB活化,最後抑制NO生合成。
Psoralidin is a natural product isolated from Psoralea corylifolia L., a herbal plant that is used in traditional Chinese medicine. The present results showed that this compound concentration (10, 20 and 30 uM)-dependently inhibited LPS-induced NO production in RAW264.7 macrophages via interfering with the activation of NF-kB/IkB/IKK and PI3K/Akt pathways,but didn’t affect MAPKs pathways activations. Furthermore, psoralidin inhibited LPS-induced IRAK1 activation and TAK1 phosphorylation. Syk is an upstream regulator of TLR4 signaling. However, the detail mechanism of Syk regulated TLR4 signaling is unclear. In this study, syk inhibitor piceatannol inhibitsed LPS-induced NO production, NF-kB, PI3K/Akt pathway and IRAK1 activations, but didn’t affect IKK/IkB pathway activation. It appears some similar action mechanisms between psoralidin and piceatannol. Transfection of siRNA targeting IRAK1, didn’t affect LPS-induced IKK/IkB pathway. Therefore, the anti-inflammatory mechanisms of psoralidin might inhibit LPS-induced IRAK1, PI3K/Akt pathway and IKK/I�菣B pathway independently and subsequently suppressing NF-k�羠 activation and NO production in RAW264.7 macrophages.
中文摘要..................................................1
英文摘要..................................... ............2
背景介紹..................................................3
壹、發炎反應(inflammation)................................3
貳、一氧化氮及一氧化氮合成酶..............................5
參、巨噬細胞的辨識系統: 類鐸受體(Toll-like receptors).....7
肆、以LPS刺激巨噬細胞所活化的NO訊息傳遞路徑...............11
伍、NF-kB/IKK 路徑........................................11
陸、絲裂原活化蛋白激酶(Mitogen-activated protein kinases, MAPKs)....................................................14
柒、PI3K/Akt 路徑.........................................15
捌、Non-receptor PTKs.....................................17
玖、Psoralidin............................................20
研究目的..................................................23
實驗材料與方法............................................24
壹、實驗藥品及材料來源....................................24
貳、緩衝液配製............................................26
参、實驗方法..............................................27
研究結果..................................................36
討論......................................................45
NO生成含量測定及psoralidin對NO生成的影響..................45
Psoralidin抑制iNOS mRNA及iNOS蛋白質含量...................45
Psoralidin抑制LPS誘導之TAK1活化卻不影響MAPKs..............46
Psoralidin抑制LPS誘導之IRAK1活化..........................46
Psoralidin影響的機轉層面..................................47
參考文獻..................................................49
圖表......................................................56
Akira, S., Takeda, K., 2004. Toll-like receptor signalling. Nat Rev Immunol 4, 499-511.
Aktan, F., 2004. iNOS-mediated nitric oxide production and its regulation. Life Sciences 75, 639-653.
Athlin, L., Holmberg, S.B., Hafstrom, L., 1991. Macrophage function and surgery. A clinical review with special reference to phagocytosis. European Journal of Surgery 157, 163-170.
Berton, G., Mocsai, A., Lowell, C.A., 2005. Src and Syk kinases: key regulators of phagocytic cell activation. Trends Immunol 26, 208-214.
Blos, M., Schleicher, U., Soares Rocha, F.J., Meissner, U., Rollinghoff, M., Bogdan, C., 2003. Organ-specific and stage-dependent control of Leishmania major infection by inducible nitric oxide synthase and phagocyte NADPH oxidase. European Journal of Immunology 33, 1224-1234.
Castellheim, A., Brekke, O.L., Espevik, T., Harboe, M., Mollnes, T.E., 2009. Innate immune responses to danger signals in systemic inflammatory response syndrome and sepsis. Scandinavian Journal of Immunology 69, 479-491.
Chen, Y., Cheung, Y.T., Kong, L.D., Ng, T.B., Qiao, C., Mo, S.F., Xu, H.X., Kung, H.F., 2008. Transcriptional regulation of corticotrophin releasing factor gene by furocoumarins isolated from seeds of Psoralea corylifolia. Life Sciences 82, 1117-1121.
Cho, H., Jun, J.Y., Song, E.K., Kang, K.H., Baek, H.Y., Ko, Y.S., Kim, Y.C., 2001. Bakuchiol: a hepatoprotective compound of Psoralea corylifolia on tacrine-induced cytotoxicity in Hep G2 cells. Planta Medica 67, 750-751.
Choi, H.S., Rai, P.R., Chu, H.W., Cool, C., Chan, E.D., 2002. Analysis of nitric oxide synthase and nitrotyrosine expression in human pulmonary tuberculosis. American Journal of Respiratory and Critical Care Medicine 166, 178-186.
Coleman, J.W., 2001. Nitric oxide in immunity and inflammation. Int Immunopharmacol 1, 1397-1406.
Cruz, M.T., Duarte, C.B., Goncalo, M., Carvalho, A.P., Lopes, M.C., 1999. Involvement of JAK2 and MAPK on type II nitric oxide synthase expression in skin-derived dendritic cells. American Journal of Physiology 277, C1050-1057.
Darieva, Z., Lasunskaia, E.B., Campos, M.N., Kipnis, T.L., Da Silva, W.D., 2004. Activation of phosphatidylinositol 3-kinase and c-Jun-N-terminal kinase cascades enhances NF-kappaB-dependent gene transcription in BCG-stimulated macrophages through promotion of p65/p300 binding. Journal of Leukocyte Biology 75, 689-697.
Gray, P., Dunne, A., Brikos, C., Jefferies, C.A., Doyle, S.L., O'Neill, L.A., 2006. MyD88 adapter-like (Mal) is phosphorylated by Bruton's tyrosine kinase during TLR2 and TLR4 signal transduction. Journal of Biological Chemistry 281, 10489-10495.
Guha, M., Mackman, N., 2001. LPS induction of gene expression in human monocytes. Cellular Signalling 13, 85-94.
Han, M., Wen, J.K., Zheng, B., Zhang, D.Q., 2004. Acetylbritannilatone suppresses NO and PGE2 synthesis in RAW 264.7 macrophages through the inhibition of iNOS and COX-2 gene expression. Life Sciences 75, 675-684.
Hu, X., Chen, J., Wang, L., Ivashkiv, L.B., 2007. Crosstalk among Jak-STAT, Toll-like receptor, and ITAM-dependent pathways in macrophage activation. Journal of Leukocyte Biology 82, 237-243.
Ivashkiv, L.B., 2008. A signal-switch hypothesis for cross-regulation of cytokine and TLR signalling pathways. Nat Rev Immunol 8, 816-822.
Jefferies, C.A., Doyle, S., Brunner, C., Dunne, A., Brint, E., Wietek, C., Walch, E., Wirth, T., O'Neill, L.A., 2003. Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4. Journal of Biological Chemistry 278, 26258-26264.
Jiang, Z., Ninomiya-Tsuji, J., Qian, Y., Matsumoto, K., Li, X., 2002. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Molecular and Cellular Biology 22, 7158-7167.
Kagan, J.C., Medzhitov, R., 2006. Phosphoinositide-mediated adaptor recruitment controls Toll-like receptor signaling. Cell 125, 943-955.
QRCODE
 
 
 
 
 
                                                                                                                                                                                                                                                                                                                                                                                                               
第一頁 上一頁 下一頁 最後一頁 top
無相關期刊